0001562180-19-000490.txt : 20190124
0001562180-19-000490.hdr.sgml : 20190124
20190124172954
ACCESSION NUMBER: 0001562180-19-000490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Elizabeth
CENTRAL INDEX KEY: 0001757545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 19540719
MAIL ADDRESS:
STREET 1: C/O SAGE THERAPEUTICS, INC.
STREET 2: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-01-22
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001757545
Barrett Elizabeth
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
true
false
false
false
Stock Options (Right to buy)
137.29
2019-01-22
4
A
false
20000.00
0.00
A
2029-01-22
Common Stock
20000.00
20000.00
D
All of the shares subject to the option vest in equal monthly installments during the 36 months following January 22, 2019 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to the reporting person's continued service as a director of the issuer through such date.
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Elizabeth Barrett
2019-01-24